FDA Approves Ultragenyx Gene Therapy
Source Summary
The FDA has approved a gene therapy from Ultragenyx for an ultra-rare disease. The approval represents a validating win for mRNA research, according to biotech news coverage.
The FDA has approved a gene therapy from Ultragenyx for an ultra-rare disease. The approval represents a validating win for mRNA research, according to biotech news coverage.
